Laura Cranston, RPh, Chief Executive Officer, Pharmacy Quality Alliance, on CMS proposed policies to strengthen and modernize the Medicare Part D program

November 29, 2018

The Pharmacy Quality Alliance (PQA) applauds CMS for considering an option to develop a standard set of metrics from which pharmacies and health plans would base their contractual agreements. PQA is the leading developer of consensus-based medication performance measures. As a neutral convener, we are ready to bring together all relevant stakeholders to develop these measures. A transparent and multi-stakeholder process is critical to creating a standard set of measures that can be widely supported and strengthen the Part D program for patients.

PQA, initially established as a public-private partnership with CMS for the development of measures within Medicare, develops nationally-recognized, endorsed performance measures that address the safe and appropriate use of medications. These measures are used for public reporting, accountability and quality improvement across federal and state programs including Medicare, Medicaid, health insurance exchanges, accrediting organizations, provider networks and other healthcare-related alliances.

With more than 250 member organizations representing pharmacists and other healthcare providers, pharmacies, health plans, pharmacy benefit managers, life sciences, technology vendors, government agencies, researchers and academia, PQA is uniquely positioned to create useful measures that advance value-based care.


Pharmacy Quality Alliance:

Centers for Medicare & Medicaid Services (CMS) proposed rule: “Modernizing Part D and Medicare Advantage to Lower Drug Prices and Reduce Out-of-Pocket Expenses”


Contact: Richard Schmitz, PQA Senior Director of Communications, [email protected] or 703-347-7931